Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Christina Mohr-Jensen |
Documentos disponibles escritos por este autor (2)
Refinar búsqueda
Association of benzodiazepines and antidepressants with 180-day mortality among patients with dementia receiving antipsychotic pharmacotherapy / Ane Nørgaard en The Journal of Clinical Psychiatry, Año 2020 - Vol. 81 - No. 4 (Julio - Agosto)
[artículo]
Título : Association of benzodiazepines and antidepressants with 180-day mortality among patients with dementia receiving antipsychotic pharmacotherapy : a nationwide registry-based study Tipo de documento: texto impreso Autores: Ane Nørgaard, Autor ; Christina Mohr-Jensen, Autor ; Christiane Gasse, Autor Fecha de publicación: 2020 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Agentes antidepresivos, Benzodiazepinas, Demencia, Tratamiento farmacológico. Resumen: Antipsychotic drugs are known to increase mortality among patients with dementia. Many patients receive concomitant treatment with other psychotropic agents. The aim of this retrospective cohort study was to investigate the impact of benzodiazepines and antidepressants on the risk of death in patients with dementia initiating antipsychotic drug treatment. Link: ./index.php?lvl=notice_display&id=24769
in The Journal of Clinical Psychiatry > Año 2020 - Vol. 81 - No. 4 (Julio - Agosto)[artículo] Association of benzodiazepines and antidepressants with 180-day mortality among patients with dementia receiving antipsychotic pharmacotherapy : a nationwide registry-based study [texto impreso] / Ane Nørgaard, Autor ; Christina Mohr-Jensen, Autor ; Christiane Gasse, Autor . - 2020.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The Journal of Clinical Psychiatry > Año 2020 - Vol. 81 - No. 4 (Julio - Agosto)
Palabras clave: Agentes antidepresivos, Benzodiazepinas, Demencia, Tratamiento farmacológico. Resumen: Antipsychotic drugs are known to increase mortality among patients with dementia. Many patients receive concomitant treatment with other psychotropic agents. The aim of this retrospective cohort study was to investigate the impact of benzodiazepines and antidepressants on the risk of death in patients with dementia initiating antipsychotic drug treatment. Link: ./index.php?lvl=notice_display&id=24769 Attention-Deficit/Hyperactivity Disorder in Childhood and Adolescence and the Risk of Crime in Young Adulthood in a Danish Nationwide Study / Christina Mohr-Jensen en Journal of the American Academy of Child & Adolescent Psychiatry, Año 2019 - Vol. 58 - No.4 (Abril)
[artículo]
Título : Attention-Deficit/Hyperactivity Disorder in Childhood and Adolescence and the Risk of Crime in Young Adulthood in a Danish Nationwide Study Tipo de documento: texto impreso Autores: Christina Mohr-Jensen, Autor ; Charlotte Müller Bisgaard, Autor ; Søren Kjærsgaard Boldsen,, Autor Fecha de publicación: 2019 Artículo en la página: pp. 443-452 Idioma : Inglés (eng) Palabras clave: TDAH, Crimen, Factor de riesgo, Resultado, Longitudinal Resumen: To determine the risk of long-term conviction and incarceration associated with childhood attention-deficit/hyperactivity disorder (ADHD), and to identify risk and protective factors including associations with active treatment with ADHD medication. Link: ./index.php?lvl=notice_display&id=20513
in Journal of the American Academy of Child & Adolescent Psychiatry > Año 2019 - Vol. 58 - No.4 (Abril) . - pp. 443-452[artículo] Attention-Deficit/Hyperactivity Disorder in Childhood and Adolescence and the Risk of Crime in Young Adulthood in a Danish Nationwide Study [texto impreso] / Christina Mohr-Jensen, Autor ; Charlotte Müller Bisgaard, Autor ; Søren Kjærsgaard Boldsen,, Autor . - 2019 . - pp. 443-452.
Idioma : Inglés (eng)
in Journal of the American Academy of Child & Adolescent Psychiatry > Año 2019 - Vol. 58 - No.4 (Abril) . - pp. 443-452
Palabras clave: TDAH, Crimen, Factor de riesgo, Resultado, Longitudinal Resumen: To determine the risk of long-term conviction and incarceration associated with childhood attention-deficit/hyperactivity disorder (ADHD), and to identify risk and protective factors including associations with active treatment with ADHD medication. Link: ./index.php?lvl=notice_display&id=20513